Point72 Asia (Singapore)’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-72,666
Closed -$449K 980
2024
Q2
$449K Buy
+72,666
New +$449K 0.09% 166